Tailoring tyrosine kinase inhibitor therapy to tackle specific BCR-ABL1 mutant clones

Alfonso Quintás-Cardama, Jorge Cortes

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Tailoring tyrosine kinase inhibitor therapy to tackle specific BCR-ABL1 mutant clones'. Together they form a unique fingerprint.

Medicine & Life Sciences